Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Mechanism map How Compounded Tirzepatide is positioned Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist that has shown up to 22.5% body weight reduction in the SURMOUNT trials
API access for automated procurement workflows (if applicable)
Hng dn s dng: Dng bc cui cng sau nc hoa hng v serum
Units depend on concentration
Supports healthy inflammation pathways in the body, helping to manage normal inflammatory responses associated with physical activity and promoting overall bodily comfort
US$ 21.87
US$ 24.54
US$ 23.89
